Pathophysiology of diabetes mellitus in Cushing's syndrome

Neuroendocrinology

Volumn 92, Issue SUPPL. 1, 2010, Pages 77-81

  Pivonello, Rosario ^a   De Leo, Monica ^a   Vitale, Pasquale ^a   Cozzolino, Alessia ^a   Simeoli, Chiara ^a   De Martino, Maria Cristina ^a   Lombardi, Gaetano ^a   Colao, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cushing's disease; Diabetes mellitus; Glucose intolerance; Hypercortisolism; Insulin resistance; Insulin sensitivity

Indexed keywords

AMINO ACID; FATTY ACID; GLUCOCORTICOID; GLUCOSE; INSULIN; INSULIN RECEPTOR;

CONFERENCE PAPER; CUSHING SYNDROME; DIABETES MELLITUS; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HUMAN; HYPERCORTISOLISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOLYSIS; LIVER METABOLISM; MUSCLE METABOLISM; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION;

CUSHING SYNDROME; DIABETES MELLITUS; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS;

EID: 77956506289     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314319     Document Type: Conference Paper

References (22)

1. Pivonello R, De Martino MC, De Leo M, Lombardi G, Colao A: Cushing's syndrome. Endocrinol Metab Clin Nort h Am 2008; 37: 135-149.
2. Resmini E, Minuto F, Colao A, Ferone D: Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Acta Diabetol 2009; 46:85-95.
3. Van Raalte DH, Ouwens DM, Diamant M: Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest 2009; 39: 81-93.
4. McMahon M, Gerich J, Rizza R: Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 1988; 4:17-30.
5. Andrews RC, Walker BR: Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci 1999; 96: 51 3-52 3.
6. Vegiopoulos A, Herzig S: Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol 2007; 275:43-61.
7. Rooney DP, Neely RD, Cullen C, et al: The effect of cortisol on glucose/glucose-6-phos-phate cycle activity in insulin action. J Clin Endocrinol Metab 1993; 77:1180-1183.
8. Vander Kooi BT, Onuma H, Oeser JK, et al: The glucose-6-phosphatase catalytic sub-unit gene promoter contains both positive and negative glucocorticoid response elements. Mol Endocrinol 2005; 19: 3001-3022.
9. Kraus-Friedman N: Hormonal regulation of hepatic gluconeogenesis. Physiol Rev 1984; 64:170-259.
10. Dirlewanger M, Schneiter PH, Paquot N, Je-quier E, Rey V, Tappy L: Effects of glucocor-ticoids on hepatic sensitivity to insulin and glucagon in man. Clin Nutr 2000; 19: 29-34.
11. Rizza RA, Mandarino LJ, Gerich JE: Corti-sol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab 1982; 54: 131-138.
12. Saad MJ, Folli F, Kahn JA, Kahn CR: Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-ki-nase in liver and muscle of dexamethasone-treated rats. J Clin Invest 1993; 92:2065-2072.
13. Weinstein SP, Wilson CM, Pritsker A, Cush-man SW: Dexamethasone inhibits insulin-stimulated recruitment of GLUT4 to the cell surface in rat skeletal muscle. Metabolism 1998; 47:3-6.
14. Ruzzin J, Wagman AS, Jensen J: Glucocorti-coid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia 2005; 48: 2119-2130.
15. Seckl JR, Morton NM, Chapman KE, Walker BR: Glucocorticoids and 11beta-hydroxy-steroid dehydrogenase in adipose tissue. Recent Prog Horm Res 2004; 59: 359-393.
16. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89:2548-2556.
17. Kahn SE: The relative contributions of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetes. Diabeto-logia 2003; 46:3-19.
18. Gremlich S, Roduit R, Thorens B: Dexa-methasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic beta cells. Comparison with the effects of fatty acids. J Biol Chem 1997; 272:3216-3222.
19. Borboni P, Porzio O, Magnaterra R, et al: Quantitative analysis of pancreatic glucoki-nase gene expression in cu ltured beta cells by competitive polymerase chain reaction. Mol Clin Endocrinol 1996; 117:175-181.
20. Ullrich S, Berchtold S, Ranta F, et al: Serum-and glucocorticoid- inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion. Diabetes 2005; 54:1090-1099.
21. Van Raalte D, Nofrate V, Bunck M, Van Iersel T, Elassaiss Schaap J, Nãssander U, Heine R, Mari A, Dokter W, Diamant M: Acute and two-week exposure to prednisolone impair different aspects of beta-cell function in healthy men. Eur J Endocrinol 2010; 162: 729-735.
22. Matsumoto K, Yamasaki H, Akazawa S, et al: High dose but not low dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta cells in normal men. J Clin Endocrinol Metab 1996; 81: 2621-2626.